Jens Fricke

Chief Operating Officer at POLYPEPTIDE GROUP AG

Net worth: 45 591 $ as of 30/04/2024

59 year

81 connections

Health Technology

Technology Services

Commercial Services

Jens Fricke active positions

Companies	Position	Start	End
POLYPEPTIDE GROUP AG	Chief Operating Officer	01/12/2022	-
Telogic A/S Telogic A/S Information Technology ServicesTechnology Services Telogic A/S provides virtual mobile network services and solutions. It is a Mobile Virtual Network Operators (MVNO) that supports fixed telephony, voice over internet protocol, and broadband. The firm provides network access either as a "Full MVNO" or in service provider setup. The company was founded by Jens Fricke, Peter Daun and Per Erik Angman in 1999 and is headquartered in Birkerod, Denmark.	Director/Board Member	24/05/2010	-
	Founder	24/05/2010	-
VICTORIA Vierte Beteiligungsgesellschaft mbH VICTORIA Vierte Beteiligungsgesellschaft mbH Miscellaneous Commercial ServicesCommercial Services Part of Münchener Rückversicherungs-Gesellschaft AG, VICTORIA Vierte Beteiligungsgesellschaft mbH provides professional, scientific and technical services. The company is based in Dusseldorf, Germany. The CEOs of the German company are Jens Fricke, Peter-Michael Kracht.	Chief Executive Officer	-	-
PolyPeptide Laboratories A/S PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark.	Director/Board Member	-	-

Career history of Jens Fricke

Former positions of Jens Fricke

Companies	Position	Start	End
LEO Pharma A/S LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.	Corporate Officer/Principal	01/01/2008	01/01/2013

Training of Jens Fricke

University of Copenhagen

Graduate Degree

Statistics

International

Denmark	5
Germany	2
Switzerland	2

Operational

Director/Board Member	2
Founder	1
Chief Executive Officer	1

Sectoral

Health Technology	3
Technology Services	2
Commercial Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	1
POLYPEPTIDE GROUP AG	Health Technology

Private companies	4
Telogic A/S Telogic A/S Information Technology ServicesTechnology Services Telogic A/S provides virtual mobile network services and solutions. It is a Mobile Virtual Network Operators (MVNO) that supports fixed telephony, voice over internet protocol, and broadband. The firm provides network access either as a "Full MVNO" or in service provider setup. The company was founded by Jens Fricke, Peter Daun and Per Erik Angman in 1999 and is headquartered in Birkerod, Denmark.	Technology Services
VICTORIA Vierte Beteiligungsgesellschaft mbH VICTORIA Vierte Beteiligungsgesellschaft mbH Miscellaneous Commercial ServicesCommercial Services Part of Münchener Rückversicherungs-Gesellschaft AG, VICTORIA Vierte Beteiligungsgesellschaft mbH provides professional, scientific and technical services. The company is based in Dusseldorf, Germany. The CEOs of the German company are Jens Fricke, Peter-Michael Kracht.	Commercial Services
PolyPeptide Laboratories A/S PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark.	Process Industries
LEO Pharma A/S LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.	Health Technology

See company connections